MedTrace Logo

Fatigue in MS: From Invisible to Measurable

NCT07182903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2026-04-20

No results posted yet for this study

Summary

Fatigue is one of the most common and burdensome symptoms of MS, but its precise cause remains unknown, and an effective treatment is lacking. Previous research has shown that the progression of MS is associated with a higher presence of a specific type of T-cell, the cytotoxic CD4+ T-cells, which play a role in the immune system.

The aim of this study is to investigate whether these cells can also be linked to fatigue in people with MS.

Conditions

Sponsors & Collaborators

  • UHasselt

    collaborator UNKNOWN

  • University Medical Center Groningen

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-27
Primary Completion
2026-04-02
Completion
2026-04-02

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07182903 on ClinicalTrials.gov